• McDonald's (NYSE:MCD) shares surged 4.16 percent to 280.63 dollars in heavy trading, with volume well above its daily average.
• Genuine Parts Company (NYSE:GPC) shares surged 12.92 percent to 132.57 dollars after a report that O'Reilly Automotive submitted a cash bid for its automotive parts business.
• A three-judge panel of the 1st U.S. Circuit Court of Appeals put on hold a judge's order requiring reinstallation of removed national park exhibits.
• The June jobs report showed just 57,000 payrolls added versus roughly 110,000 expected.
• Crude prices dropped roughly 1-4% on the day amid cautious optimism around U.S.-Iran peace talks in Doha.
• Two Very Different Scientific Approaches: Elicio's ELI-002 7P is an immune-activating cancer vaccine while Revolution Medicines' daraxonrasib is a direct small molecule RAS inhibitor targeting the same disease.
• Two Distinct Isotope Approaches: Telix uses lutetium-177 (beta emitter) in prostate cancer while Molecular Partners employs lead-212 (alpha emitter) in small cell lung cancer.
• Only Oral Formulation of Levosimendan in Phase 3: If successful, oral levosimendan would be the first oral formulation of an established IV heart failure inotrope to reach approval.
• Eight Companies With Simultaneous Catalysts: A single session produced FDA clearances, clinical data, capital raises, compliance notices, buybacks, reverse splits, patent grants, and biocompatibility results across eight companies.
• The pullback follows a remarkable year-to-date surge of over 144%.